0000899243-19-024830.txt : 20191002
0000899243-19-024830.hdr.sgml : 20191002
20191002213856
ACCESSION NUMBER: 0000899243-19-024830
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191002
FILED AS OF DATE: 20191002
DATE AS OF CHANGE: 20191002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LeBel Carl
CENTRAL INDEX KEY: 0001439275
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 191134178
MAIL ADDRESS:
STREET 1: 23256 MARIPOSA DE ORO
CITY: MALIBU
STATE: CA
ZIP: 90265
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY, SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY, SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-02
0
0001703647
Frequency Therapeutics, Inc.
FREQ
0001439275
LeBel Carl
C/O FREQUENCY THERAPEUTICS, INC.,
19 PRESIDENTIAL WAY, 2ND FLOOR
WOBURN
MA
01801
0
1
0
0
Chief Development Officer
Stock Option
3.37
2019-04-17
4
A
0
23555
0.00
A
2029-04-16
Common Stock
23555
23555
D
Stock Option
3.37
2019-04-17
4
A
0
101930
0.00
A
2029-04-16
Common Stock
101930
101930
D
Stock Option
14.00
2019-10-02
4
A
0
178937
0.00
A
2029-10-01
Common Stock
178937
178937
D
This transaction is being reported pursuant to Rule 16a-2(a), and the securities covered by such transaction were previously included on the Reporting Person's Form 3.
The option is fully vested.
The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2019, and will be fully vested and exercisable on January 1, 2023.
The option vests and becomes exercisable in equal monthly installments over a four year period commencing on November 2, 2019, and will be fully vested and exercisable on October 2, 2023.
By: /s/ Michael D. Bookman, Attorney-in-Fact for Carl P. LeBel
2019-10-02